Zobrazeno 1 - 10
of 584
pro vyhledávání: '"Pär Stattin"'
Publikováno v:
PLoS ONE, Vol 19, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/bb9468a6470642309518fe9436f0c53a
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 13732-13744 (2023)
Abstract Background Insulin resistance has been shown to be related to a higher risk of several cancers, but the association with prostate cancer (PCa) has been inconsistent. Methods We investigated prediagnostic markers of insulin resistance in men
Externí odkaz:
https://doaj.org/article/1a28bc1fc2fd4e41a95dcb75d16a6878
Autor:
Eugenio Ventimiglia, Anna Bill-Axelson, Jan Adolfsson, Markus Aly, Martin Eklund, Marcus Westerberg, Pär Stattin, Hans Garmo
Publikováno v:
European Urology Open Science, Vol 44, Iss , Pp 46-51 (2022)
Background: Little is known about disease trajectories for men with castration-resistant prostate cancer (CRPC). Objective: To create a state transition model that estimates time spent in the CRPC state and its outcomes. Design, setting, and particip
Externí odkaz:
https://doaj.org/article/85d3a094259c49b2bb543a344ae02efc
Autor:
Robert J. Klein, Emily Vertosick, Dan Sjoberg, David Ulmert, Ann-Charlotte Rönn, Christel Häggström, Elin Thysell, Göran Hallmans, Anders Dahlin, Pär Stattin, Olle Melander, Andrew Vickers, Hans Lilja
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-8 (2022)
Abstract Polygenic risk scores (PRS) for prostate cancer incidence have been proposed to optimize prostate cancer screening. Prediction of lethal prostate cancer is key to any stratified screening program to avoid excessive overdiagnosis. Herein, PRS
Externí odkaz:
https://doaj.org/article/5f0a0b867c3d40ad97478098664fd2bd
Publikováno v:
BMC Urology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Epidemiological data on anticoagulation for venous thromboembolism (VTE) in prostate cancer are sparse. We aimed to investigate associations between anticoagulation duration and risks of VTE recurrence after treatment cessation an
Externí odkaz:
https://doaj.org/article/1e963667535e4f41a88d0d4127aa4d16
Autor:
Mieke Van Hemelrijck, Eugenio Ventimiglia, David Robinson, Rolf Gedeborg, Lars Holmberg, Pär Stattin, Hans Garmo
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-20 (2022)
Abstract Introduction For clinical decision-making, an estimate of remaining lifetime is needed to assess benefit against harm of a treatment during the remaining lifespan. Here, we describe how to predict life expectancy based on age, Charlson Comor
Externí odkaz:
https://doaj.org/article/afafe7730b1244d9a1b61b959fbba258
Autor:
E. Lin, Hans Garmo, Mieke Van Hemelrijck, Jan Adolfsson, Pär Stattin, Björn Zethelius, Danielle Crawley
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Gonadotropin Releasing Hormones agonists (GnRH), which are first line treatment for metastatic prostate cancer (PCa), increase risk of type 2 diabetes mellitus (T2DM). This study aims to quantify the association of use of GnRH wit
Externí odkaz:
https://doaj.org/article/99c33006006c4a96a64c57146bddbb8f
Autor:
Richard Shore, Jingru Yu, Weimin Ye, Jesper Lagergren, Martin Rutegård, Olof Akre, Pär Stattin, Mats Lindblad
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract The aim of this study was to explore the male predominance in esophageal and gastric adenocarcinoma by evaluating the preventive potential of androgen deprivation therapy (ADT). This matched cohort study was based on a national Swedish datab
Externí odkaz:
https://doaj.org/article/5613e691bb464c97b6d04ced585359f4
Autor:
Sylvia H. J. Jochems, Angela M. Wood, Christel Häggström, Marju Orho‐Melander, Pär Stattin, Tanja Stocks
Publikováno v:
Cancer Medicine, Vol 10, Iss 8, Pp 2885-2896 (2021)
Abstract We recently found a negative association between body mass index (BMI) and the risk of localised prostate cancer (PCa), no association with advanced PCa, and a positive association with PCa‐specific mortality. In a 15% subpopulation of tha
Externí odkaz:
https://doaj.org/article/1cdbae403af94bff84eacf80233ef0f0
Autor:
Andri Wilberg Orrason, Marcus Westerberg, Peter Albertsen, Johan Styrke, David Robinson, Hans Garmo, Pär Stattin
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0277784 (2022)
The main aim of the study was to determine the impact of diagnostic activity and life expectancy on the lifetime risk of a prostate cancer diagnosis. We used a state transition simulation model based on Swedish population-based data to simulate life
Externí odkaz:
https://doaj.org/article/2ad4b3c7ca05497797e8f90e36342c53